GeneScience Pharmaceuticalsshanghai, China (People's Republic)
Disclosure information not submitted.
SAT-233 - Gensci134, A Long-Acting GHR-Agonistic VHH-Fc Fusion Protein, Demonstrates Sustained GH-Mimetic Activity and Enhanced Metabolic and Skeletal Effects in Preclinical Models
Saturday, June 13, 20269:30 AM - 4:30 PM CT
SUN-180 - Gensci155, A Novel Long-Acting IGF-1 Analog Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in A Neonatal Rat Model
Sunday, June 14, 20269:00 AM - 4:00 PM CT
SUN-741 - Gensci144, A Novel SLC6A19 Inhibitor, Demonstrates Renoprotective Efficacy in A Humanized SLC6A19 Mouse Model of Aristolochic Acid Nephropathy
.jpg)
.jpg)